ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Tofacitinib Impurity 19
Tofacitinib Impurity 19
- CAS No.
- 2056104-91-5
- Chemical Name:
- Tofacitinib Impurity 19
- Synonyms
- Tofatinib Impurity 19;Tofacitinib Impurity 133;N-((3S,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity);7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3S,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]-
- CBNumber:
- CB34842524
- Molecular Formula:
- C27H31N5O2S
- Molecular Weight:
- 489.63
- MOL File:
- 2056104-91-5.mol
Tofacitinib Impurity 19 Preparation Products And Raw materials
Raw materials
Preparation Products
Tofacitinib Impurity 19 Suppliers
Global( 12)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 | China | 11927 | 58 | Inquiry |
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd | 18502726233; 18502726233 | China | 9808 | 58 | Inquiry |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 | China | 8346 | 55 | Inquiry |
Nantong Hanfang Biotechnology Co. , Ltd. | 18616537568 | China | 30968 | 58 | Inquiry |
Shanghai Haohong Scientific Co., Ltd. | 400-400-8210725 | China | 39990 | 58 | Inquiry |
Changzhou Bojia Biomedical Technology Co., Ltd. | 2122619822 | China | 18488 | 58 | Inquiry |
Molcoo Chemicals Inc. | 18627923403 18627753421 | China | 9284 | 58 | Inquiry |
Hubei Moco Chemical Co., Ltd. | 18576690171 | China | 10993 | 58 | Inquiry |
Guangzhou Dreampharm Biotechnology Co., Ltd. | 020-36607679 17825480238 | China | 9919 | 12 | Inquiry |
2056104-91-5(Tofacitinib Impurity 19)Related Search:
4-(Hydroxyamino)-4-oxobutanoic acid
CYANOACETIC ACID-OSU
N-Hydroxysuccinimide
Tofacitinib Impurity 2
Ethyl S-4-chloro-3-hydroxybutyrate
2-amino-4-fluoro-5-nitrobenzoic acid
TF-A
(3R,4R)-N,4-dimethyl-piperidin-3-amine
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine
Tofacitinib Impurity 20
R-afatinib
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
chevron_left
1of4
chevron_right
Tofacitinib Impurity 133
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3S,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]-
Tofatinib Impurity 19
N-((3S,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)
2056104-91-5